Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Retinyl palmitate is an ester of retinol (vitamin A) and palmitic acid, serving as a major storage form of vitamin A in the body. It is a fat-soluble compound involved in supporting vision, immune function, skin health, growth, and reproduction. Retinyl palmitate acts by being converted into active forms of vitamin A such as retinoic acid and retinal that regulate gene expression through nuclear receptors affecting cell differentiation and proliferation. It is used to prevent or treat vitamin A deficiency conditions including night blindness and xerophthalmia. Topically, it has applications for improving photoaged skin quality and acne treatment due to its role in skin cell turnover. It can be administered orally or by injection for supplementation purposes[2][3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on retinyl palmitate.